Catherine Schulte
Stock Analyst at Baird
(1.49)
# 1673
Out of 5,370 analysts
141
Total ratings
50.93%
Success rate
6.57%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
A Agilent Technologies | Maintains: Outperform | 159 140 | 119.07 | 17.58% | 16 | May 22, 2025 | |
MRVI Maravai LifeSciences | Maintains: Neutral | 3 2 | 2.15 | -6.98% | 6 | May 13, 2025 | |
EXAS Exact Sciences | Maintains: Outperform | 69 72 | 53.29 | 35.11% | 14 | May 2, 2025 | |
AVTR Avantor | Maintains: Outperform | 21 17 | 13.43 | 26.58% | 11 | Apr 28, 2025 | |
TMO Thermo Fisher Scient... | Maintains: Outperform | 603 573 | 404.82 | 41.54% | 26 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 231 225 | 200.98 | 11.95% | 9 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1369 1034 | 1182.83 | -12.58% | 8 | Apr 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 43 | 47.42 | -9.32% | 4 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 88 68 | 51.56 | 31.89% | 10 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 182 165 | n/a | n/a | 6 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 19.23 | 97.61% | 7 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 33 | 35.01 | -5.74% | 3 | Nov 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 1 | Jun 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 335 281 | 90.09 | 211.91% | 6 | Sep 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | May 26, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 29 | n/a | n/a | 5 | Apr 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 208 217 | 347.88 | -37.62% | 7 | Oct 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 168.2 | -88.11% | 1 | Jun 28, 2018 |